LEAN · Compound 01
Triple-receptor agonist, GLP-1 / GIP / glucagon
Retatrutide is an investigational triple-receptor agonist engaging the GLP-1, GIP, and glucagon pathways at once, the compound behind some of the most closely-watched metabolic research of the decade.
Limited supplyTracked, cold-chain and discreetly packaged. Choose your speed at checkout.
Also: request a COA or a wholesale quote.
Retatrutide represents the current frontier of incretin research: a single synthetic peptide engineered to activate three metabolic receptors at once, GLP-1, GIP and glucagon. Where earlier compounds engaged one or two of these pathways, its triple-agonist design lets researchers probe how they behave when stimulated in concert.
That breadth is exactly what has made it one of the most closely watched molecules in metabolic science. The glucagon arm, layered on top of the incretin effect, opens questions about energy expenditure that dual agonists cannot reach, which is why comparative protocols increasingly treat Retatrutide as the reference point.
For a compound this pharmacologically busy, material fidelity is everything: a single impurity or a mislabelled strength can quietly skew results across three separate pathways. Every ONE% batch is identity-confirmed and purity-verified by Janoshik before release, so dosing stays consistent between studies.
Mechanism In Brief
Retatrutide binds and activates the GLP-1, GIP and glucagon receptors simultaneously, combining incretin-driven glucose regulation with glucagon-mediated energy signalling.
Every ONE% compound ships as a lyophilised powder for stability in transit. Reconstitute with bacteriostatic water to the concentration your protocol requires, store at 2–8°C protected from light, and use within your laboratory’s validated window. Each vial is batch-referenced to its Janoshik Certificate of Analysis, available on request.
Important
For research and laboratory use only. Retatrutide is supplied strictly as premium-grade research material with a batch Certificate of Analysis. It is not a drug, supplement, food, or cosmetic, and is not intended for human or veterinary use, diagnosis, treatment, or the prevention of any condition. All statements describe published research directions only.

The Proof
Third-party tested, every batch. Every Certificate of Analysis released with the vial, not on request.
Complete Your Kit
The instrument and the consumables that go with the range. Reusable pen, cartridges, and the essentials.






Good To Know
It ships as a lyophilised (freeze-dried) powder. In the lab it's reconstituted with bacteriostatic water to the concentration your protocol requires. Kept sealed, cold and dark, it stays stable until you need it.
Sealed at 2–8°C, protected from light. As a lyophilised powder it's stable in transit; once reconstituted, follow your laboratory's validated window.
No, every compound ships as a lyophilised vial and is reconstituted in the lab. The ONE% Pen is a separate reusable instrument for laboratories that want repeatable, graduated delivery instead of drawing by syringe each time. Buy it once; it is not tied to any one compound.
Every vial carries a batch code. Enter it on our batch verification page to pull up that batch’s Certificate of Analysis, or ask us for the certificate before you order, we would rather you check than take our word for it.
It is the target every batch of Retatrutide is held to, measured by HPLC at Janoshik and reported on the COA as a percentage of the total peptide content. Identity is confirmed separately by mass spectrometry. A purity figure without a named method and a batch reference behind it is marketing, not data.
Education · Read Before You Buy
One molecule, three metabolic receptors, and why it became the reference point for the field’s most-watched research.
Read the deep-dive →Continue
Talk To Us
Ask for a Certificate of Analysis, a specific batch, or anything else, send a note and we answer as fast as we test.
info@onepercentpeptides.com